Page last updated: 2024-10-24

chlorambucil and Long Sleeper Syndrome

chlorambucil has been researched along with Long Sleeper Syndrome in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holtzer-Goor, KM1
Schaafsma, MR1
Joosten, P1
Posthuma, EF1
Wittebol, S1
Huijgens, PC1
Mattijssen, EJ1
Vreugdenhil, G1
Visser, H1
Peters, WG1
Erjavec, Z1
Wijermans, PW1
Daenen, SM1
van der Hem, KG1
van Oers, MH1
Uyl-de Groot, CA1

Other Studies

1 other study available for chlorambucil and Long Sleeper Syndrome

ArticleYear
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2015, Volume: 24, Issue:12

    Topics: Adult; Aged; Chlorambucil; Dyspnea; Fatigue; Female; Health Status; Humans; Leukemia, Lymphocytic, C

2015